B. Riley Issues Pessimistic Outlook for Abacus Life Earnings

Abacus Life, Inc. (NASDAQ:ABL) – Equities research analysts at B. Riley decreased their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a note issued to investors on Wednesday, April 9th. B. Riley analyst R. Binner now expects that the company will earn $0.14 per share for the quarter, down from their previous forecast of $0.15. B. Riley has a “Buy” rating and a $15.00 price objective on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life’s Q2 2025 earnings at $0.16 EPS and Q4 2025 earnings at $0.26 EPS.

Separately, Piper Sandler lowered their price target on Abacus Life from $13.00 to $11.50 and set an “overweight” rating on the stock in a research report on Tuesday. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $14.00.

Abacus Life Trading Up 10.1 %

Shares of ABL opened at $7.85 on Thursday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65. The stock has a market cap of $760.30 million, a PE ratio of -43.61 and a beta of 0.16. Abacus Life has a 1 year low of $6.34 and a 1 year high of $12.50. The stock has a 50 day simple moving average of $7.49 and a 200-day simple moving average of $8.05.

Abacus Life (NASDAQ:ABL) last announced its quarterly earnings results on Thursday, March 27th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. The firm had revenue of $33.21 million during the quarter, compared to analysts’ expectations of $28.76 million.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of ABL. Alyeska Investment Group L.P. increased its holdings in Abacus Life by 116.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,540,790 shares of the company’s stock valued at $19,894,000 after purchasing an additional 1,367,210 shares in the last quarter. Royce & Associates LP increased its stake in shares of Abacus Life by 339.9% in the fourth quarter. Royce & Associates LP now owns 1,306,431 shares of the company’s stock valued at $10,229,000 after buying an additional 1,009,431 shares in the last quarter. Kennedy Capital Management LLC bought a new position in shares of Abacus Life in the fourth quarter valued at about $7,461,000. Monashee Investment Management LLC bought a new position in shares of Abacus Life in the fourth quarter valued at about $6,342,000. Finally, Mendon Capital Advisors Corp lifted its position in Abacus Life by 137.1% during the 4th quarter. Mendon Capital Advisors Corp now owns 1,303,826 shares of the company’s stock worth $10,209,000 after buying an additional 753,826 shares in the last quarter.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.